Perrigo CEO Ousted Over Personal Conduct
Perrigo Chief Executive Patrick Lockwood-Taylor has resigned after the board found his personal conduct had violated company code.
Perrigo: This 11% Yielder Should Cut The Dividend
Perrigo is rated Hold due to a distressed balance sheet, high leverage, and unsustainable dividend coverage. PRGO's 10.9% dividend yield is not covered by free cash flow, with near-term risk of a dividend cut unless further divestitures occur. Recent asset sales, including the Dermacosmetics business, provide short-term relief but dilute margins and highlight the need for portfolio consolidation.
Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?
Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y
PRGO beats Q1 EPS estimates despite lower sales. Weakness in cough and cold demand offsets gains in Women's Health and Infant Formula.
Perrigo Company plc (PRGO) Q1 2026 Earnings Call Transcript
Perrigo Company plc (PRGO) Q1 2026 Earnings Call Transcript
Perrigo (PRGO) Q1 Earnings Beat Estimates
Perrigo (PRGO) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.6 per share a year ago.
Perrigo: Double-Digit Dividend At A Bargain Price
Perrigo offers a compelling value with a 12% dividend yield and a P/E of 4.3, trading at a deep discount to fair value. PRGO is refocused on its core OTC store-brand business, prioritizing cost savings and operational efficiencies after divestitures and past acquisition missteps. Management's Three-S Plan targets $80M–$100M in annual cost savings by 2027, supporting margin improvement and sustainable dividend growth.
Perrigo Company plc (PRGO) Presents at UBS Global Consumer and Retail Conference Transcript
Perrigo Company plc (PRGO) Presents at UBS Global Consumer and Retail Conference Transcript
PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View
Perrigo misses Q4 EPS estimates. Its 2026 sales and profit estimates are below expectations as Infant Formula headwinds persist.
Why Perrigo (PRGO) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Perrigo (PRGO) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Perrigo (PRGO) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Perrigo (PRGO) Q4 Earnings Lag Estimates
Perrigo (PRGO) came out with quarterly earnings of $0.77 per share, missing the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $0.93 per share a year ago.
